Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
US10150784B2 · kind B2 · utility
0Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 18, 2016 |
| Grant date | Dec 11, 2018 |
| Priority date | — |
| Expiry date | Jul 18, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F3/003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable characteristics for the same. The invention further provides processes for the production of solid forms of magnesium glycinate dihydrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.